Latest News

Shine On Progress Update Mid-Year 2

The vision “to create a world where we no longer fear cancer” drives the work of Dr. Jaime Modiano and his colleagues in the Animal Cancer Care and Research Program of the University of Minnesota College of Veterinary Medicine. The “Shine On” study represents a turning point in their efforts to achieve this vision, by finding a way to prevent hemangiosarcoma, an aggressive, malignant tumor of blood vessel cells, in dogs.

Continue reading “Shine On Progress Update Mid-Year 2”

Microphthalmia and Delayed Growth Syndrome

PARKER FORD, PA, February 1, 2017 – The Portuguese Water Dog Foundation is pleased to announce we have signed a Memorandum of Understanding (MOU) along with the Portuguese Water Dog Club of America to collaborate with AKC CHF to jointly fund research at the University of Pennsylvania (UPENN) – Section of Medical Genetics, Pediatrics and Reproduction to better characterize the clinical disorder of syndromic microphthalmia and delayed growth seen in the PWD, commonly known in our breed as Puppy Eye Syndrome (PES). Continue reading “Microphthalmia and Delayed Growth Syndrome”

Update End-Year 2 (Final)- Health Implication of Early Spay Neuter

Summary: Final update on findings at the end-year 2 in a study to develop a generalized understanding of the impact of early spay and neuter on disease risk in dogs. The goal of this project was to evaluate, using one consistent and uniform database at their large veterinary medical center (UC Davis). This update provides conclusions for several medium-to-large breed dogs regarding the impact of early spay/neuter on cancer and musculoskeletal risks. Several additional breeds were evaluated since last update. Additionally, several small breeds were evaluated determining negligible risk with early spay/neuter. Findings indicate risk vary from breed to breed.

Continue reading “Update End-Year 2 (Final)- Health Implication of Early Spay Neuter”

Research Update End-Year 2 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk

End-year 2 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma. Progress continues in the researcher’s efforts into this population of B cell lymphomas similar to the aggressive form seen in humans.

Continue reading “Research Update End-Year 2 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk”